Allergy and Immunology · Saint Charles, IL
NPI
1811970486
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2435 Dean St Unit C
Saint Charles, IL, 60175
Phone (630) 584-6127
Groups this clinician bills Medicare through
Medicare paid, 2024
$335K
13,465 services
Medicare patients, 2024
140
Average age 71
Drug cost, 2024
$1.5M
999 prescriptions
Company payments, 2025
$358K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Priya J Bansal was code 95004 (test - miscellaneous), 1,483 times for 26 patients. In total Priya J Bansal billed 13,465 services in 31 codes, and Medicare paid $335K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,483 | 26 | $3.02 | $4,481 |
| 95165 Treatment - Miscellaneous | Office | 1,030 | 25 | $11.32 | $12K |
| 95117 Treatment - Miscellaneous | Office | 347 | 23 | $8.31 | $2,882 |
| 99214 Office E&M - Established | Office | 240 | 110 | $93.57 | $22K |
| 96401 Chemotherapy Administration | Office | 165 | 13 | $58.99 | $9,733 |
| 96160 E&M - Miscellaneous | Office | 145 | 65 | $2.25 | $326 |
| 95012 Pulmonary | Office | 100 | 70 | $15.04 | $1,504 |
| 99204 Office E&M - New | Office | 43 | 43 | $132.68 | $5,705 |
| 94060 Pulmonary Function Testing | Office | 34 | 33 | $30.82 | $1,048 |
| 94010 Pulmonary Function Testing | Office | 34 | 33 | $22.04 | $749 |
| 94664 E&M - Miscellaneous | Office | 15 | 14 | $13.38 | $201 |
By year: 2022 $190K for 6,275 services; 2023 $241K for 9,177 services; 2024 $335K for 13,465 services.
Medicare prescription drug claims, 2024
In 2024, the drug Priya J Bansal prescribed most often to Medicare patients was Montelukast Sodium, with 94 prescriptions and refills. In total Priya J Bansal wrote 999 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 94 | 268 | 31 | $1,495 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 70 | 114 | 23 | $71K |
| Arnuity Ellipta Fluticasone Furoate | 60 | 80 | 19 | $20K |
| Azelastine Hcl Generic | 59 | 119 | 35 | $2,422 |
| Levocetirizine Dihydrochloride Generic | 54 | 160 | 23 | $1,411 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 49 | 74 | 29 | $1,672 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 30 | 36 | Under 11 | $6,871 |
| Xhance Fluticasone Propionate | 30 | 44 | Under 11 | $44K |
| Breo Ellipta Fluticasone/Vilanterol | 30 | 42 | 11 | $16K |
| Fluticasone Propionate Generic | 27 | 58 | 14 | $487 |
| Ipratropium Bromide Generic | 25 | 39 | 11 | $922 |
| Azithromycin Generic | 25 | 25 | 22 | $102 |
| Prednisone Generic | 23 | 23 | 16 | $96.67 |
| Epinephrine Generic | 23 | 23 | 16 | $3,672 |
| Spiriva Respimat Tiotropium Bromide | 22 | 30 | Under 11 | $15K |
Brand drugs: 447 claims; generic drugs: 552 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Priya J Bansal $358K ($358K in general payments such as food, travel and fees) from 34 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $76K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 87 | $76K |
| Regeneron Healthcare Solutions, Inc. REGN | 45 | $57K |
| Novartis Pharmaceuticals Corporation NVS | 41 | $41K |
| CSL Behring CSL.AX | 52 | $40K |
| Lilly USA, LLC LLY | 44 | $38K |
| Genzyme Corporation SNY | 37 | $31K |
| GlaxoSmithKline, LLC. GSK | 34 | $14K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 18 | $13K |
| Ionis Pharmaceuticals, Inc. IONS | 15 | $8,905 |
| Pharming Healthcare, Inc. | 28 | $7,118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.